Related Experiment Video
Updated: Aug 23, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Factor D
Hideharu Sekine1, Takeshi Machida1, Teizo Fujita2
1Department of Immunology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Insights
Complement factor D (FD) activation, crucial for the alternative pathway (AP), requires MASP-3. This discovery clarifies how FD is physiologically activated, impacting complement system research.
Area of Science:
- Immunology
- Biochemistry
- Complement System Biology
Background:
- Complement factor D (FD) is a serine protease essential for alternative pathway (AP) activation.
- FD, primarily from adipose tissue, circulates in an activated form, unlike most liver-synthesized complement proteases.
- The mechanism of FD activation remained largely unknown until recent discoveries.
Purpose of the Study:
- To elucidate the mechanism of complement factor D (FD) activation.
- To investigate the role of MASP-1 and MASP-3 in FD activation.
- To clarify the physiological activation of the AP via FD.
Main Methods:
- Utilized MASP-1/3-deficient mice and MASP-1 or MASP-3 monospecific knockout mice.
- Analyzed sera from these knockout mice for lectin pathway (LP) and AP activity.
- Examined sera from 3MC syndrome patients with MASP1 gene mutations.
Main Results:
- MASP-1/3-deficient mice sera showed minimal LP and AP activity with pro-FD.
- MASP-1-deficient mice sera lacked LP activity.
- MASP-3-deficient mice sera lacked AP activity with pro-FD, indicating MASP-3's crucial role.
Conclusions:
- MASP-1 and/or MASP-3 are involved in the activation of FD.
- MASP-3 plays a pivotal role in the physiological activation of the AP through FD activation.
- This research clarifies a key step in complement system regulation.
Abstract:
Complement factor D (FD) is a serine protease that plays an essential role in the activation of the alternative pathway (AP) by cleaving complement factor B (FB) and generating the C3 convertases C3(H2 O)Bb and C3bBb. FD is produced mainly from adipose tissue and circulates in an activated form. On the contrary, the other serine proteases of the complement system are mainly synthesized in the liver. The activation mechanism of FD has long been unknown. Recently, a serendipitous discovery in the mechanism of FD activation has been provided by a generation of Masp1 gene knockout mice lacking both the serine protease MASP-1 and its alternative splicing variant MASP-3, designated MASP-1/3-deficient mice. Sera from the MASP-1/3-deficient mice had little-to-no lectin pathway (LP) and AP activity with circulating zymogen or proenzyme FD (pro-FD). Sera from patients with 3MC syndrome carrying mutations in the MASP1 gene also had circulating pro-FD, suggesting that MASP-1 and/or MASP-3 are involved in activation of FD. Here, we summarize the current knowledge of the mechanism of FD activation that was finally elucidated using the sera of mice monospecifically deficient for MASP-1 or MASP-3. Sera of the MASP-1-deficient mice lacked LP activity, but those of the MASP-3-deficient mice lacked AP activity with pro-FD. This review illustrates the pivotal role of MASP-3 in the physiological activation of the AP via activation of FD.
More Related Videos
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

